series-b
Stage
1
Investors
About
Kainova Therapeutics is a clinical-stage biotechnology company developing therapies that target G protein-coupled receptors (GPCRs) for the treatment of immuno-oncology and inflammatory diseases, with lead programs including antibodies and small molecules at various clinical stages.
Explore Kainova Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.